Windlas Biotech Key Ratios
NSE: WINDLAS | BSE: 543329
₹961.25
As on 20-Nov-2026IST
Market cap
₹1,984 Cr
Revenue (TTM)
₹984 Cr
P/E Ratio
29.8
P/B Ratio
3.5
Div. Yield
0.7 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 6.37 | 18.66 | 18.48 | 20.81 | 16.92 |
| EBIT | 11.81 | 3.88 | 0.29 | 12.35 | 12.74 |
| Net Profit | 2.26 | 1.42 | -0.45 | 12.58 | 14.97 |
| EPS | 2.26 | 3.59 | 0.18 | 12.77 | 15.06 |
| Book Value | -- | -- | 11.34 | 11.68 | 19.44 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 9.04 | 9.02 | 7.64 | 8.18 | 8.70 |
| Net Margin
| 8.01 | 8.06 | 6.66 | 7.21 | 7.84 |
| Return on equity
| 13.03 | 12.56 | 11.60 | 12.52 | 12.90 |
| Return on Capital
| 17.13 | 16.16 | -- | 16.06 | 17.12 |
| Return on Assets
| 8.94 | 8.99 | 7.29 | 7.97 | 8.80 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.05 | 0.05 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
--
|
16.05
|
17.04
|
18.31
|
14.38
|
|
Peer Median
|
--
|
21.28
|
21.76
|
21.89
|
--
|
ROE
11.60
Lower than Peers by 3.33
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
11.60
|
12.51
|
12.82
|
13.76
|
10.75
|
|
Peer Median
|
14.92
|
18.29
|
17.93
|
16.42
|
--
|
ROA
7.29
Lower than Peers by 2.57
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
7.29
|
7.97
|
8.75
|
10.09
|
8.39
|
|
Peer Median
|
9.85
|
9.88
|
12.81
|
12.32
|
--
|
EBIT Margin
7.64
Lower than Peers by 10.04
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
7.64
|
8.18
|
8.70
|
10.25
|
9.33
|
|
Peer Median
|
17.68
|
18.36
|
18.93
|
21.05
|
--
|
Net Margin
6.66
Lower than Peers by 7.11
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
6.66
|
7.21
|
7.80
|
9.02
|
8.15
|
|
Peer Median
|
13.77
|
13.31
|
14.94
|
15.51
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
--
|
10.75
|
11.66
|
11.35
|
10.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
18.48
Higher than Peers by 5.82
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
18.48
|
18.98
|
20.43
|
22.97
|
10.12
|
|
Peer Median
|
12.65
|
16.05
|
10.90
|
13.44
|
--
|
EBIT Growth
0.29
Lower than Peers by 23.11
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
0.29
|
11.83
|
2.28
|
35.05
|
17.50
|
|
Peer Median
|
23.39
|
20.72
|
15.01
|
23.50
|
--
|
Net Profit Growth
-0.45
Lower than Peers by 23.23
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
-0.45
|
9.54
|
4.31
|
36.35
|
10.59
|
|
Peer Median
|
22.78
|
20.10
|
14.80
|
30.12
|
--
|
EPS Growth
0.18
Lower than Peers by 21.22
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
0.18
|
8.78
|
3.50
|
37.19
|
15.18
|
|
Peer Median
|
21.40
|
19.29
|
14.27
|
29.02
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
--
|
12.11
|
12.38
|
11.39
|
1.66
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
--
|
0.05
|
0.05
|
0.00
|
0.00
|
|
Peer Median
|
0.00
|
0.05
|
0.06
|
0.03
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
--
|
0.05
|
0.05
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.66
Lower than Peers by 0.37
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
1.66
|
1.95
|
2.11
|
2.52
|
2.92
|
|
Peer Median
|
2.03
|
1.90
|
1.90
|
2.23
|
--
|
Quick Ratio
1.40
Lower than Peers by 0.14
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
1.40
|
1.76
|
1.78
|
2.15
|
2.31
|
|
Peer Median
|
1.54
|
1.40
|
1.46
|
1.59
|
--
|
Interest Coverage
13.81
Lower than Peers by 7.95
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
13.81
|
19.02
|
19.12
|
70.83
|
73.59
|
|
Peer Median
|
21.76
|
19.02
|
24.96
|
45.29
|
--
|
Operating Efficiency
Debtors to sales
29.34
Higher than Peers by 8.09
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
29.34
|
25.15
|
21.96
|
21.60
|
22.78
|
|
Peer Median
|
21.25
|
20.44
|
21.77
|
20.10
|
--
|
Asset Turnover
1.08
Higher than Peers by 0.35
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
1.08
|
1.08
|
1.10
|
1.09
|
1.01
|
|
Peer Median
|
0.72
|
0.74
|
0.76
|
0.81
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
--
|
79.59
|
72.81
|
73.22
|
80.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
--
|
28.91
|
34.48
|
39.61
|
47.47
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
--
|
140.29
|
124.26
|
106.52
|
91.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
--
|
-31.79
|
-16.97
|
6.30
|
36.68
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
29.76
Lower than Peers by 3.06
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
29.76
|
23.43
|
35.98
|
18.33
|
11.05
|
|
Peer Median
|
32.82
|
32.82
|
26.81
|
39.85
|
--
|
Price / Book Value
3.49
Lower than Peers by 0.80
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
3.49
|
2.77
|
4.36
|
2.39
|
1.18
|
|
Peer Median
|
4.29
|
4.39
|
4.65
|
6.11
|
--
|
Dividend Yield
0.66
Higher than Peers by 0.21
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
0.66
|
0.85
|
0.56
|
1.07
|
1.78
|
|
Peer Median
|
0.44
|
0.46
|
0.61
|
0.37
|
--
|
EV/EBITDA
16.41
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
16.41
|
12.94
|
19.63
|
11.30
|
6.36
|
|
Peer Median
|
--
|
24.76
|
27.02
|
34.57
|
--
|
Market Cap
1,984
Lower than Peers by 14,650
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Windlas Biotech
|
1,984
|
1,557
|
2,182
|
1,066
|
471
|
|
Peer Median
|
16,634
|
15,421
|
20,914
|
25,297
|
--
|